Inactivation of specific β cell transcription factors in type 2 diabetes
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes (T2DM) commonly arises from islet β cell failure and insulin resistance. Here, we examined the sensitivity of key islet-enriched transcription factors to oxidative stress, a condition associated with β cell dysfunction in both type 1 diabetes (T1DM) and T2DM. Hydrogen peroxide treatment of β cell lines induced cytoplasmic translocation of MAFA and NKX6.1. In parallel, the ability of nuclear PDX1 to bind endogenous target gene promoters was also dramatically reduced, whereas the activity of other key β cell transcriptional regulators was unaffected. MAFA levels were reduced, followed by a reduction in NKX6.1 upon development of hyperglycemia in db/db mice, a T2DM model. Transgenic expression of the glutathione peroxidase-1 antioxidant enzyme (GPX1) in db/db islet β cells restored nuclear MAFA, nuclear NKX6.1, and β cell function in vivo. Notably, the selective decrease in MAFA, NKX6.1, and PDX1 expression was found in human T2DM islets. MAFB, a MAFA-related transcription factor expressed in human β cells, was also severely compromised. We propose that MAFA, MAFB, NKX6.1, and PDX1 activity provides a gauge of islet β cell function, with loss of MAFA (and/or MAFB) representing an early indicator of β cell inactivity and the subsequent deficit of more impactful NKX6.1 (and/or PDX1) resulting in overt dysfunction associated with T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative stress can inactivate key islet transcription factors, producing “stunned” β-cells that temporarily stop responding to glucose and storing normal amounts of insulin ( 36 , 37 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303 · cited 1×
“Time PCR Experiments (MIQE) guidelines were followed (78).”
Identification and expression cloning of a leptin receptor, OB-R.
Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496 · cited 1×
“The db/db mouse is a model of obesity and T2DM due to a deficiency in leptin receptor activity (45, 46).”
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232 · cited 1×
“Oxidative stress induces modifications within proteins, and these modifications impact activity (55, 56), stability (57, 58), and/or subcellular distribution (40, 41).”
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214 · cited 1×
“The db/db mouse is a model of obesity and T2DM due to a deficiency in leptin receptor activity (45, 46).”
Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells
D'Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G., Moorman, M. A., Kroon, E., Carpenter, M. K., & Baetge, E. E. (2006) · Nature Biotechnology · doi:10.1038/nbt1259 · Cited by 1,915
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415 · cited 4×
“parity and aging in mice lacking FOXO1 in β cells (47).”
InfluentialTiedge, M., Lortz, S., Drinkgern, J., & Lenzen, S. (1997) · Diabetes · doi:10.2337/diab.46.11.1733 · Cited by 1,208 · cited 1×
“Nota-bly, islet β cells have unusually low antioxidant enzyme levels (e.g., glutathione peroxidase-1 [GPX1] and catalase), thus exposing their proteins, lipids, and/or DNA to oxidative modifications (10, 11).”
Five stages of evolving beta-cell dysfunction during progression to diabetes
Weir, G. C., & Bonner-Weir, S. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s16 · Cited by 1,126
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078 · cited 2×
“These data suggest that β cell inactivity results from the stepwise loss of MAFA and then PDX1 under glucotoxic conditions (22, 23, 28).”
Self-citationAhlgren, U., Jonsson, J., Jonsson, L., Simu, K., & Edlund, H. (1998) · Genes & Development · doi:10.1101/gad.12.12.1763 · Cited by 918
Type 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Oxidative Stress and Cell Signalling
Poli, G., Leonarduzzi, G., Biasi, F., & Chiarpotto, E. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365323 · Cited by 722 · cited 1×
“Oxidative stress induces modifications within proteins, and these modifications impact activity (55, 56), stability (57, 58), and/or subcellular distribution (40, 41).”
Kaneto, H., Kajimoto, Y., Miyagawa, J., Matsuoka, T., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., & Hori, M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2398 · Cited by 712 · cited 2×
“Interestingly, the N-acetyl-L-cysteine antioxidant improved both MAFA (referred to as RIPE3b1 activator) and PDX1 gel-shift–binding ability as well as β cell function in HIT-T15 β cells and in the ZDF T2DM rat model (3, 4).”
Park, J. H., Stoffers, D. A., Nicholls, R. D., & Simmons, R. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33655 · Cited by 640
Pancreas organogenesis: From bud to plexus to gland
Pan, F. C., & Wright, C. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22584 · Cited by 614 · cited 1×
“Maturity-onset diabetes of the young (MODY) typically results from mutations in islet-enriched transcription factors, with 6 of 9 MODY genes encoding transcription factors that are required in β cell development and/or function (15, 16).”
FoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction
Kitamura, Y. I., Kitamura, T., Kruse, J.-P., Raum, J. C., Stein, R., Gu, W., & Accili, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.004 · Cited by 556 · cited 6×
“Oxidative stress induces modifications within proteins, and these modifications impact activity (55, 56), stability (57, 58), and/or subcellular distribution (40, 41).”
InfluentialSelf-citationGrankvist, K., Marklund, S. L., & Täljedal, I. B. (1981) · Biochemical Journal · doi:10.1042/bj1990393 · Cited by 517 · cited 1×
“Nota-bly, islet β cells have unusually low antioxidant enzyme levels (e.g., glutathione peroxidase-1 [GPX1] and catalase), thus exposing their proteins, lipids, and/or DNA to oxidative modifications (10, 11).”
Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.
Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., & Baekkeskov, S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9037 · Cited by 515 · cited 1×
“(71), αTC-6 (72), MIN6 (73), and βTC-3 (74) cells were grown as described.”
Ihara, Y., Toyokuni, S., Uchida, K., Odaka, H., Tanaka, T., Ikeda, H., Hiai, H., Seino, Y., & Yamada, Y. (1999) · Diabetes · doi:10.2337/diabetes.48.4.927 · Cited by 506
MafA Is a Key Regulator of Glucose-Stimulated Insulin Secretion
Zhang, C., Moriguchi, T., Kajihara, M., Esaki, R., Harada, A., Shimohata, H., Oishi, H., Hamada, M., Morito, N., Hasegawa, K., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4969-4976.2005 · Cited by 488 · cited 3×
“1 and GLUT2 subcellular levels to normal (Figure 6); GLUT2 is the β cell’s principal glucose transporter and is MAFA regulated (17).”
Parsons, J. A. (1992) · Endocrinology · doi:10.1210/en.130.3.1459 · Cited by 476 · cited 1×
“A normal response to conditions of reduced peripheral insulin sensitivity, also seen during pregnancy, is increased β cell proliferation to improve insulin availability (48–51).”
Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes
Del Guerra, S., Lupi, R., Marselli, L., Masini, M., Bugliani, M., Sbrana, S., Torri, S., Pollera, M., Boggi, U., Mosca, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.727 · Cited by 466
Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants
Tanaka, Y., Gleason, C. E., Tran, P. O. T., Harmon, J. S., & Robertson, R. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10857 · Cited by 459 · cited 2×
“Interestingly, the N-acetyl-L-cysteine antioxidant improved both MAFA (referred to as RIPE3b1 activator) and PDX1 gel-shift–binding ability as well as β cell function in HIT-T15 β cells and in the ZDF T2DM rat model (3, 4).”
Self-citationReduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion
Brissova, M., Shiota, M., Nicholson, W. E., Gannon, M., Knobel, S. M., Piston, D. W., Wright, C. V. E., & Powers, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111272200 · Cited by 375
Self-citationSalehi, M., Prigeon, R. L., & D’Alessio, D. A. (2011) · Diabetes · doi:10.2337/db11-0203 · Cited by 323
Tiedge, M., Lortz, S., Drinkgern, J., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.11.1733 · Cited by 304
A switch from MafB to MafA expression accompanies differentiation to pancreatic β-cells
Nishimura, W., Kondo, T., Salameh, T., El Khattabi, I., Dodge, R., Bonner-Weir, S., & Sharma, A. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.02.028 · Cited by 297
Members of the Large Maf Transcription Family Regulate Insulin Gene Transcription in Islet β Cells
Matsuoka, T.-A., Zhao, L., Artner, I., Jarrett, H. W., Friedman, D., Means, A., & Stein, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6049-6062.2003 · Cited by 293
Self-citationSwingle, M., Ni, L., & Honkanen, R. E. (2007) · Protein Phosphatase Protocols · doi:10.1385/1-59745-267-x:23 · Cited by 290 · cited 1×
“Pretreatment of β TC-3 cells with oka-diac acid, an inhibitor of endogenous protein phosphatase (PP) 1 and 2A (36), prevented this change in mobility (Figure 1B).”
Hotta, M., Tashiro, F., Ikegami, H., Niwa, H., Ogihara, T., Yodoi, J., & Miyazaki, J.-I. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1445 · Cited by 251
MafB is required for islet β cell maturation
Artner, I., Blanchi, B., Raum, J. C., Guo, M., Kaneko, T., Cordes, S., Sieweke, M., & Stein, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700013104 · Cited by 244
Self-citationMafA and MafB Regulate Genes Critical to β-Cells in a Unique Temporal Manner
Artner, I., Hang, Y., Mazur, M., Yamamoto, T., Guo, M., Lindner, J., Magnuson, M. A., & Stein, R. (2010) · Diabetes · doi:10.2337/db10-0190 · Cited by 243 · cited 6×
“The susceptibility of MAFA to oxidative inactivation was compared with MAFB, a closely related islet-enriched protein (18, 38, 39).”
InfluentialSelf-citationRegulation of the Insulin Gene by Glucose and Fatty Acids
Poitout, V., Hagman, D., Stein, R., Artner, I., Robertson, R. P., & Harmon, J. S. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.4.873 · Cited by 242 · cited 1×
“These data suggest that β cell inactivity results from the stepwise loss of MAFA and then PDX1 under glucotoxic conditions (22, 23, 28).”
Self-citationSchaffer, A. E., Taylor, B. L., Benthuysen, J. R., Liu, J., Thorel, F., Yuan, W., Jiao, Y., Kaestner, K. H., Herrera, P. L., Magnuson, M. A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003274 · Cited by 240
Self-citationThe role of dysregulated glucagon secretion in type 2 diabetes
D'Alessio, D. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01449.x · Cited by 238 · cited 1×
“It will be interesting to explore whether this reduction in MAFB contributes to dysregulated glucagon secretion in human T2DM patients (62).”
Harmon, J. S., Stein, R., & Robertson, R. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410345200 · Cited by 233 · cited 3×
“Moreover, earlier work also indicates that MAFA activity precedes the loss of PDX1 during glucotoxicity (23).”
Self-citationElsner, M., Gehrmann, W., & Lenzen, S. (2011) · Diabetes · doi:10.2337/db09-1401 · Cited by 221
Transcriptomes of the major human pancreatic cell types
Dorrell, C., Schug, J., Lin, C. F., Canaday, P. S., Fox, A. J., Smirnova, O., Bonnah, R., Streeter, P. R., Stoeckert, C. J., Kaestner, K. H., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2283-5 · Cited by 216 · cited 2×
“MAFB was also assessed, since this large MAF factor is coexpressed with MAFA in human islet β cells (52, 53), a situation not found in rodents (38, 54).”
Artner, I., Le Lay, J., Hang, Y., Elghazi, L., Schisler, J. C., Henderson, E., Sosa-Pineda, B., & Stein, R. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0946 · Cited by 212
Self-citationNKX6 transcription factor activity is required for α- andβ-cell development in the pancreas
Henseleit, K. D., Nelson, S. B., Kuhlbrodt, K., Hennings, J. C., Ericson, J., & Sander, M. (2005) · Development · doi:10.1242/dev.01875 · Cited by 200
Self-citationPiganelli, J. D., Flores, S. C., Cruz, C., Koepp, J., Batinic-Haberle, I., Crapo, J., Day, B., Kachadourian, R., Young, R., Bradley, B., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.2.347 · Cited by 191 · cited 1×
“Importantly, antioxidant treatment can prevent the onset of diabetes in animal models of T1DM (6, 12) as well as improve β cell function in T2DM animal models (3–6, 12, 13) and human T2DM islets (8, 9, 14).”
Harmon, J. S., Bogdani, M., Parazzoli, S. D., Mak, S. S. M., Oseid, E. A., Berghmans, M., LeBoeuf, R. C., & Robertson, R. P. (2009) · Endocrinology · doi:10.1210/en.2009-0708 · Cited by 182
Self-citationIslet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets
Dai, C., Brissova, M., Hang, Y., Thompson, C., Poffenberger, G., Shostak, A., Chen, Z., Stein, R., & Powers, A. C. (2012) · Diabetologia · doi:10.1007/s00125-011-2369-0 · Cited by 179 · cited 3×
“MAFB was also assessed, since this large MAF factor is coexpressed with MAFA in human islet β cells (52, 53), a situation not found in rodents (38, 54).”
Self-citationBottino, R., Balamurugan, A. N., Bertera, S., Pietropaolo, M., Trucco, M., & Piganelli, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2561 · Cited by 177
The Stunned β Cell: A Brief History
Ferrannini, E. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.009 · Cited by 175
Genetics of type 2 diabetes mellitus
Malecki, M. T. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.003 · Cited by 175 · cited 1×
“Several islet-enriched transcription factors have been linked to MODY (e.g., HNF4 α [MODY1], HNF1 α [MODY3], PDX1 [MODY4], NEUROD1 [MODY6]) (15, 61), a rare autosomal dominant form of diabetes.”
Sachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 158
Schisler, J. C., Jensen, P. B., Taylor, D. G., Becker, T. C., Knop, F. K., Takekawa, S., German, M., Weir, G. C., Lu, D., Mirmira, R. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502168102 · Cited by 158
Fujitani, Y., Fujitani, S., Boyer, D. F., Gannon, M., Kawaguchi, Y., Ray, M., Shiota, M., Stein, R. W., Magnuson, M. A., & Wright, C. V. E. (2006) · Genes & Development · doi:10.1101/gad.1360106 · Cited by 158
Self-citationChang, C.-J., Mulholland, D. J., Valamehr, B., Mosessian, S., Sellers, W. R., & Wu, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00310-08 · Cited by 155 · cited 2×
“However, the non– β cell lines were responsive to H 2 O 2 treatment (40), as noted, for example, by the translocation of the FOXO1 transcription factor from the cytoplasm to the nucleus in α TC-6 cells (Figure 2D), which occurs under a variety of different stress conditions (41, 42).”
Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes
Ashery‐Padan, R., Zhou, X., Marquardt, T., Herrera, P. L., Toube, L., Berry, A., & Gruß, P. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.01.040 · Cited by 154 · cited 1×
“20, 21).”
Gurgul, E., Lortz, S., Tiedge, M., Jörns, A., & Lenzen, S. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2271 · Cited by 150
PAX6 Mutation as a Genetic Factor Common to Aniridia and Glucose Intolerance
Yasuda, T., Kajimoto, Y., Fujitani, Y., Watada, H., Yamamoto, S., Watarai, T., Umayahara, Y., Matsuhisa, M., Gorogawa, S.-I., Kuwayama, Y., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.1.224 · Cited by 144 · cited 1×
“20, 21).”
Hamaguchi, K., & Leiter, E. H. (1990) · Diabetes · doi:10.2337/diab.39.4.415 · Cited by 136
GSK-3-Mediated Phosphorylation Enhances Maf-Transforming Activity
Rocques, N., Zeid, N. A., Sii-Felice, K., Lecoin, L., Felder‐Schmittbuhl, M., Eychène, A., & Pouponnot, C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.009 · Cited by 132
Raum, J. C., Gerrish, K., Artner, I., Henderson, E., Guo, M., Sussel, L., Schisler, J. C., Newgard, C. B., & Stein, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00249-06 · Cited by 128
Self-citationGANNON, M. A., Gamer, L. W., & Wright, C. V. E. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0359 · Cited by 111
Phosphorylation-Dependent Nucleocytoplasmic Shuttling of Pancreatic Duodenal Homeobox-1
Elrick, L. J., & Docherty, K. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2244 · Cited by 111 · cited 2×
“In addition, PDX1 shuttling between the nuclear periphery and nucleoplasm is phosphorylation dependent and regulated by external stimuli (i.e., glucose and insulin) (37).”
Khanday, F. A., Yamamori, T., Mattagajasingh, I., Zhang, Z., Bugayenko, A., Naqvi, A., Santhanam, L., Nabi, N., Kasuno, K., Day, B. W., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0570 · Cited by 99 · cited 1×
“Oxidative stress induces modifications within proteins, and these modifications impact activity (55, 56), stability (57, 58), and/or subcellular distribution (40, 41).”
Phosphorylation of MafA Is Essential for Its Transcriptional and Biological Properties
Benkhelifa‐Ziyyat, S., Provot, S., Nabais, E., Eychène, A., Calothy, G., & Felder‐Schmittbuhl, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4441-4452.2001 · Cited by 97 · cited 1×
“MAFA is heavily phosphorylated in vivo, a post-translational modification regulating dimerization and DNA binding, transactivation capacity, and stability (32–35).”
Regulation of MafA Expression in Pancreatic β-Cells in db/db Mice With Diabetes
Matsuoka, T., Kaneto, H., Miyatsuka, T., Yamamoto, T., Yamamoto, K., Kato, K., Shimomura, I., Stein, R. W., & Matsuhisa, M. (2010) · Diabetes · doi:10.2337/db08-0693 · Cited by 96
Self-citationStephens, S. B., Schisler, J. C., Hohmeier, H. E., An, J., Sun, A. Y., Pitt, G. S., & Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.011 · Cited by 89
Shiraiwa, T., Kaneto, H., Miyatsuka, T., Kato, K., Yamamoto, K., Kawashima, A., Kanda, T., Suzuki, M., Imano, E., Matsuhisa, M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2806 · Cited by 88 · cited 1×
“postprandial hyperglycemia in human prediabetics (59, 60).”
Rabiee, A., Magruder, J. T., Salas-Carrillo, R., Carlson, O., Egan, J. M., Askin, F. B., Elahi, D., & Andersen, D. K. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2010.09.047 · Cited by 80 · cited 1×
“…by the NIH, the Juvenile Diabetes Research Foundation (JDRF), the Islet Cell Resource Centers, and the Integrated Islet glucose control observed within weeks after bariatric surgery in T2DM patients (66, 67), a proposal supported by the increase in PDX1 protein levels seen upon recovery (66).”
Hussain, S. A.-R. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.089 · Cited by 77
Ohno, T., Kato, N., Ishii, C., Shimizu, M., Ito, Y., Tomono, S., & Kawazu, S. (1993) · Endocrine Research · doi:10.1080/07435809309026682 · Cited by 70 · cited 5×
“Adenovirus-expressed catalase was provided by Chris Rhodes (University of Chicago, Chicago, Illinois, USA), and infection of β TC-3 and MIN6 cells occurred prior to H 2 O 2 treatment.”
InfluentialRebolledo, O. R., & Dato, S. M. A. (2005) · PubMed · Cited by 69
Lupi, R., Guerra, S. D., Mancarella, R., Novelli, M., Valgimigli, L., Pedulli, G. F., Paolini, M., Soleti, A., Filipponi, F., Mosca, F., et al. (2007) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.03.005 · Cited by 64 · cited 3×
“The insulin secretion defects in human T2DM islets were also improved in vitro upon treatment with ROS scavengers (8, 9, 14).”
Sumoylation Regulates the Transcriptional Activity of MafA in Pancreatic β Cells
Shao, C., & Cobb, M. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806286200 · Cited by 48
p38 MAPK Is a Major Regulator of MafA Protein Stability under Oxidative Stress
Kondo, T., Khattabi, I. E., Nishimura, W., Laybutt, D. R., Geraldes, P., Shah, S., King, G., Bonner-Weir, S., Weir, G., & Sharma, A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0482 · Cited by 45 · cited 1×
“Oxidative stress induces modifications within proteins, and these modifications impact activity (55, 56), stability (57, 58), and/or subcellular distribution (40, 41).”
Guo, S., Burnette, R., Zhao, L., Vanderford, N. L., Poitout, V., Hagman, D. K., Henderson, E., Özcan, S., Wadzinski, B. E., & Stein, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806314200 · Cited by 43
Self-citationThe role of pancreatic imaging in monogenic diabetes mellitus
Haldorsen, I. S., Ræder, H., Vesterhus, M. N., Molven, A., & Njølstad, P. R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.197 · Cited by 43 · cited 2×
“9 MODY genes encoding transcription factors that are required in β cell development and/or function (15, 16).”
Zhao, L., Cissell, M. A., Henderson, E., Colbran, R. J., & Stein, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10532 · Cited by 39 · cited 1×
“ing activity with 32P-labeled rat insulin II C1 element (−126TGGAAACTGCAGCTTCAGCCCCTCTG−101) (76), and PDX1 with Mafa region 3 site (−8087ATTACCCATTTCTGTTAATTTGTTCTGGA−8063) (75).”
Self-citationBonny, C., Roduit, R., Gremlich, S., NICOD, P. H., Thorens, B., & Waeber, G. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00190-1 · Cited by 37
The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress
Yan, L., Guo, S., Brault, M., Harmon, J., Robertson, R. P., Hamid, R., Stein, R., & Yang, E. (2012) · Biochemical Journal · doi:10.1042/bj20111606 · Cited by 31
Self-citationPhosphorylation within the MafA N Terminus Regulates C-terminal Dimerization and DNA Binding
Guo, S., Vanderford, N. L., & Stein, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105759 · Cited by 31 · cited 3×
“In addition, the sucrose gradient sedimentation properties of MAFA were impacted by H 2 O 2 treatment, with localization now exclusively in the fraction containing high molecular weight proteins and not in the approximately 92 kD MAFA species capable of DNA binding (Figure 1F) (35).”
Self-citationD’Aleo, V., Guerra, S. D., Martano, M., Bonamassa, B., Canistro, D., Soleti, A., Valgimigli, L., Paolini, M., Filipponi, F., Boggi, U., et al. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.05.010 · Cited by 26 · cited 3×
“The insulin secretion defects in human T2DM islets were also improved in vitro upon treatment with ROS scavengers (8, 9, 14).”
Hamaguchi, K., & Leiter, E. H. (1990) · Diabetes · doi:10.2337/diabetes.39.4.415 · Cited by 24
Li, J., Bergmann, A., Reimann, M., Schulze, J., Bornstein, S., & Schwarz, P. E. H. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-992156 · Cited by 6 · cited 1×
“19; and PAX6, refs.”
Hosokawa, K., Yamaguchi, H., Ikehara, T., Takahashi, A., & Miyamoto, H. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041440211 · Cited by 3 · cited 1×
“(71), αTC-6 (72), MIN6 (73), and βTC-3 (74) cells were grown as described.”
Research works printed but not linked: 2
- Swingle, 2007, Methods Mol Biol., 365, 23
- Rebolledo, 2005, Eur Rev Med Pharmacol Sci., 9, 191
Cited by
Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus
Yaribeygi, H., Sathyapalan, T., Atkin, S. L., & Sahebkar, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8609213 · Cited by 685
“These transcriptional mediators are highly sensitive to the redox imbalance, and exposure to higher levels of free radicals negatively modulates the proliferation of the beta cell [71, 72].”
BackgroundControlled induction of human pancreatic progenitors produces functional beta‐like cells in vitro
Russ, H. A., Parent, A. V., Ringler, J. J., Hennings, T. G., Nair, G. G., Shveygert, M., Guo, T., Puri, S., Haataja, L., Cirulli, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591058 · Cited by 591
Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes
Cinti, F., Bouchi, R., Kim-Muller, J. Y., Ohmura, Y., Sandoval, P. R., Masini, M., Marselli, L., Suleiman, M., Ratner, L. E., Marchetti, P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2860 · Cited by 550
Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.019 · Cited by 489
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Self-citation
Metadata
- Authors
- Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R.
- Affiliations
- Vanderbilt University (US)
- University of California San Diego (US)
- University of Washington (US)
- Corresponding author
- Stein, Roland
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-01
- Volume
- 123
- Issue
- 8
- Pages
- 3305-3316
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726150
- OpenAlex
- W2117574263
- Cited by
- 520
- References
- 80
- Citations by year
- 2026: 33 · 2025: 30 · 2024: 39 · 2023: 38 · 2022: 45 · 2021: 55 · 2020: 35 · 2019: 43 · 2018: 29 · 2017: 38 · 2016: 45 · 2015: 52 · 2014: 32 · 2013: 6
- FWCI
- 44.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000666)
- Vanderbilt University (DK59637, DK20593, DK58404, CA68485, EY08126, HD15052)
- Vanderbilt University Medical Center (HD15052, DK20593, EY08126, DK58404, CA68485, DK59637)
- National Institutes of Health (5p60dk020593-31, DK-59637, EY08126, CA68485, DK 20593, HD-15052, DK-58404, DK66636)
- Vanderbilt Diabetes Research and Training Center, Vanderbilt University Medical Center (DK-20593)
- National Eye Institute (P30EY008126)
- National Cancer Institute (P30CA068485)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK68854, DK-090570, DK089538, P60-DK020593, U01DK089572, DK-89572, DK66636, DK59637, DK-72473, R21DK066636, R21DK068854, DK-58404, DK 20593, U01DK089538, U24DK059637, R56DK038325, DK068471, DK050203, DK038325, R01DK069603, R01DK038325, R33DK066636, R01DK050203, U01DK072473, R56DK050203, R01DK068471, P30DK058404, P30DK020593, R01DK090570)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- type 2 diabetes, pancreatic beta cells, beta-cell dysfunction, transcription factors, MafA, MAFB, NKX6.1, PDX1, oxidative stress, hydrogen peroxide, glutathione peroxidase 1, db/db mice, insulin resistance, islet function, nuclear translocation
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, HeLa Cells, Humans, Organ Specificity, Transcription Factors, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.